Literature DB >> 34113040

Drugmakers go nuclear, continuing push into radiopharmaceuticals.

Elie Dolgin1.   

Abstract

Year:  2021        PMID： 34113040     DOI： 10.1038/s41587-021-00954-z

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

Review 1.  Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals.

Authors:  Xu Zhou; Linlin Dong; Langtao Shen
Journal:  Molecules       Date:  2021-11-19       Impact factor: 4.411

2.  Capturing an elusive but critical element: Natural protein enables actinium chemistry.

Authors:  Gauthier J-P Deblonde; Joseph A Mattocks; Ziye Dong; Paul T Wooddy; Joseph A Cotruvo; Mavrik Zavarin
Journal:  Sci Adv       Date:  2021-10-20       Impact factor: 14.136

Review 3.  Radiolabeled PSMA Inhibitors.

Authors:  Oliver C Neels; Klaus Kopka; Christos Liolios; Ali Afshar-Oromieh
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.